These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33238852)

  • 1. Quinoline-3-Carboxylic Acids: A Step Toward Highly Selective Antiproliferative Agent.
    Mittal RK; Purohit P
    Anticancer Agents Med Chem; 2021; 21(13):1708-1716. PubMed ID: 33238852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent.
    Mittal RK; Purohit P
    Anticancer Agents Med Chem; 2020; 20(16):1981-1991. PubMed ID: 32560612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines.
    Podeszwa B; Niedbala H; Polanski J; Musiol R; Tabak D; Finster J; Serafin K; Milczarek M; Wietrzyk J; Boryczka S; Mol W; Jampilek J; Dohnal J; Kalinowski DS; Richardson DR
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6138-41. PubMed ID: 17904844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
    El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
    Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
    Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
    Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
    Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
    Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
    Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
    Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
    Arafa RK; Hegazy GH; Piazza GA; Abadi AH
    Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and docking study of new quinoline derivatives as antitumor agents.
    Nasr EE; Mostafa AS; El-Sayed MAA; Massoud MAM
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800355. PubMed ID: 31081954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
    Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
    Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.
    Fernández-Sáez N; Rubio-Ruiz B; Campos JM; Unciti-Broceta A; Carrión MD; Camacho ME
    Future Med Chem; 2019 Jan; 11(2):83-95. PubMed ID: 30644318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Furo[2,3-b]quinoline Derivatives with Anti-Breast Cancer Property by Targeting Topoisomerase II.
    Wang Y; Li N; Jiang N; Chen L; Sun J
    Anticancer Agents Med Chem; 2021; 21(12):1482-1489. PubMed ID: 33155915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers.
    Lo WF; Chou YW; Tseng CH; Shiu YH; Chen YW; Yang SC; Chen YL; Lin MF; Tzeng CC
    Anticancer Agents Med Chem; 2015; 15(4):493-500. PubMed ID: 25612680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies.
    Koh EJ; El-Gamal MI; Oh CH; Lee SH; Sim T; Kim G; Choi HS; Hong JH; Lee SG; Yoo KH
    Eur J Med Chem; 2013; 70():10-21. PubMed ID: 24128410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies.
    Petrović MM; Roschger C; Chaudary S; Zierer A; Mladenović M; Jakovljević K; Marković V; Botta B; Joksović MD
    Bioorg Chem; 2020 Dec; 105():104373. PubMed ID: 33074120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Phenyl quinoline derivatives as potential serotonin receptor ligands with antiproliferative activity.
    Joshi PV; Sayed AA; RaviKumar A; Puranik VG; Zinjarde SS
    Eur J Med Chem; 2017 Aug; 136():246-258. PubMed ID: 28499170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents.
    Malayeri SO; Abnous K; Arab A; Akaberi M; Mehri S; Zarghi A; Ghodsi R
    Bioorg Med Chem; 2017 Feb; 25(3):1294-1302. PubMed ID: 28073608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer.
    Chaube UJ; Rawal R; Jha AB; Variya B; Bhatt HG
    Bioorg Chem; 2021 Jan; 106():104501. PubMed ID: 33280832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.